Roberta L. Beauchamp - Department of Ophthalmology, Harvard Medical School

基本信息

浏览量：24

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 66 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

TSC2 Loss in Neural Progenitor Cells Suppresses Translation of ASD/NDD-associated Transcripts in an Mtorc1- and MNK1/2-reversible Fashion

Pauline Martin,Krzysztof J Szkop,Francis Robert,Srirupa Bhattacharyya,Roberta L Beauchamp, Jacob Brenner, Nicholas E Redmond,Sidong Huang,Serkan Erdin,Ola Larsson,Vijaya Ramesh

bioRxiv the preprint server for biology (2024)

引用0浏览0WOS引用

Preclinical Evaluation of the Third-Generation, Bi-Steric Mtorc1-Selective Inhibitor RMC-6272 in NF2-deficient Models

Srirupa Bhattacharyya,Janet L. Oblinger,Roberta L. Beauchamp, Lili Kosa,Françis Robert,Scott R. Plotkin,Long‐Sheng Chang,Vijaya Ramesh

Neuro-Oncology Advancesno. 1 (2024)

引用0浏览0引用

Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models

Srirupa Bhattacharyya,Janet L. Oblinger,Roberta L. Beauchamp, Lili Kosa,Francis Robert,Scott R. Plotkin,Long-Sheng Chang,Vijaya Ramesh

NEURO-ONCOLOGY ADVANCESno. 1 (2024): vdae024-vdae024

引用0浏览0WOS引用

Proteasomal Pathway Inhibition As a Potential Therapy for NF2-associated Meningioma and Schwannoma

Srirupa Bhattacharyya,Janet L. Oblinger,Roberta L. Beauchamp,Zhenzhen Yin,Serkan Erdin,Priya Koundinya,Anna D. Ware,Marc Ferrer,Justin T. Jordan,Scott R. Plotkin,Lei Xu,Long-Sheng Chang,Vijaya Ramesh

NEURO-ONCOLOGY（2023）

引用0浏览0WOS引用

Comparison of Therapeutic Efficacy of Gene Therapy for Tuberous Sclerosis Type 2 with Standard of Care Everolimus in Preclinical Model (S14.002)

Edwina Abou Haidar,Shilpa Prabhakar,Pike See Cheah,Sevda Lule,Roberta L. Beauchamp,Akiko Yoshinaga,Alexandra L. Geffrey,Anat Stemmer-Rachamimov,Vijaya Ramesh, Casey A. Maguire, Xandra O. Breakefield

Neurologyno. 17_supplement_2 (2023)

引用0浏览0引用

Comparison of Therapeutic Efficacy of Gene Therapy for Tuberous Sclerosis Type 2 with Standard of Care Everolimus in Preclinical Model

Edwina Abou Haidar,Shilpa Prabhakar,Pike See Cheah,Sevda Lule,Roberta L. Beauchamp,Akiko Yoshinaga,Alexandra L. Geffrey,Anat Stemmer-Rachamimov,Vijaya Ramesh,Casey A. Maguire,Xandra O. Breakefield

NEUROLOGYno. 17 (2023)

引用0浏览0引用

Supplementary Figure 1 from Regulation of Mtor Complex 2 Signaling in Neurofibromatosis 2–deficient Target Cell Types

Marianne F. James,Elizabeth Stivison,Roberta Beauchamp,Sangyeul Han,Hua Li,Margaret R. Wallace,James F. Gusella,Anat O. Stemmer-Rachamimov,Vijaya Ramesh

crossref（2023）

引用0浏览0引用

Translatome Analysis of Tuberous Sclerosis Complex 1 Patient-Derived Neural Progenitor Cells Reveals Rapamycin-Dependent and Independent Alterations

Inci S. Aksoylu,Pauline Martin,Francis Robert,Krzysztof J. Szkop, Nicholas E. Redmond,Srirupa Bhattacharyya, Jennifer Wang,Shan Chen,Roberta L. Beauchamp,Irene Nobeli,Jerry Pelletier,Ola Larsson,Vijaya Ramesh

MOLECULAR AUTISMno. 1 (2023)

引用0浏览0WOS引用

Prospective Phase II Trial of the Dual Mtorc1/2 Inhibitor Vistusertib for Progressive or Symptomatic Meningiomas in Persons with Neurofibromatosis 2

Justin T. Jordan,Christina C. Orr,Raquel D. Thalheimer, Josephine Cambillo,Roberta L. Beauchamp,Ghalib Shaikh,Alona Muzikansky,Anat Stemmer-Rachamimov,Marco Giovannini,Michel Kalamarides,Fred G. Barker,Vijaya Ramesh,Scott R. Plotkin

NEURO-ONCOLOGY ADVANCESno. 1 (2023)

引用0浏览0WOS引用

Gene Replacement Therapy in a Schwannoma Mouse Model of Neurofibromatosis Type 2

Shilpa Prabhakar,Roberta L. Beauchamp,Pike See Cheah,Akiko Yoshinaga,Edwina Abou Haidar,Sevda Lule, Gayathri Mani,Katia Maalouf,Anat Stemmer-Rachamimov,David H. Jung,Bradley Welling,Marco Giovannini,Scott R. Plotkin,Casey A. Maguire,Vijaya Ramesh,Xandra O. Breakefield

Molecular Therapy — Methods & Clinical Development（2022）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn